Filter announcements
Loading...
Beta Drugs Ltd is engaged in manufacturing of a wide range of oncology (anti-cancer) drugs in India. It has operations in the domestic and export markets.
Beta Drugs posted strong Q1-FY27 results. Revenue surged to 125.5 Cr, up 25.2% YoY, with profit (PAT) climbing 41.0% YoY to 16.5 Cr. Earnings per share (EPS) grew 27.5% to INR 14.78. This robust performance was driven by exceptional growth in branded oncology (+47% YoY) and contract manufacturing (CMO) (+41%...